1. Trandaburu T，Nurnberger F，Ali SS，et al.Distribution and ultrastructure of somatostat in immunoreactive cells in the pancreas.Anat Anz，1995，177：213-216.

2. Ahren B，Larsson H.Impaired glucose tolerance（IGT）is associated with reduced insulin-induced suppression of glucagon concentrations.Diabetologia，2001，44：1998-2003.

3. Larsson H，Ahren B.Glucose intolerance is predicted by low insulin secretion and high glucagon secretion：outcome of a prospective study in postmenopausal Caucasian women.Diabetologia，2000，43：194-202.

4. Henkel E，Menschikowski M，Koehler C，et al.Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.Metabolism，2005，54（9）：1168-1173.

5. Diao J，Asghar Z，Chan CB，et al.Glucose-regulated glucagons secretion requires insulin receptor expression in pancreatic alpha-cells. J Biol Chem，2005，280（39）：33487-33496.

6. Leung YM，Ahmed I，Sheu L，et al.Insulin regulates islet { alpha} -cell function by reducing KATP channel sensitivity to ATP inhibition.Endocrinology，2006，2：1130-1135.

7. Leung YM，Ahmed I，Sheu L，et al. Electrophysiological characterization of pancreatic islet cells in the mouse insulin promoter-green fluorescent protein mouse.Endocrinology，2005，146（11）：4766-4775.

8. Kaneko K，Shirotani T，Araki E，et al.Insulin inhibits glucagons secretion by the activation of PI3-kinase in In-R1-G9 cells.Diabetes Res Clin Pract，1999，44：83-92.

9. Greenbaum CJ，Prigeon RL，D'Alessio DA.Impaired-cell function，incretin effect，and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes，2002；51：951-957.

10. Wang ZL，Bennet WZ，Wang RM，et al.Evidence of a pancreatic role of Neuropeptide Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone treated rats.Endocrinology，1994，135：200-206.

11. Zoccali C.Neuropeptide Y as a far reaching neuromediator：from energy balance and cardiovascular regulation to central integration of weight and bone mass control mechanisms.Implications for human diseases.Curr Op in Nephrol Hypertens，2005，14（1）：25-32.

12. Yuzuriha H，Inui A，Goo K，et al.Intracerebroventricular administration of NPY stimulates resistin gene expression in mice.Int J Mol Med，2003，11（5）：675-676.

13. Sainsbury A，Schwarzer C，CouzensM，et al.Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob m ice.Diabetes，2002，51（12）：3420-3427.

14. Moller N，Bagger JP，Schmitz O，et al.Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.J Clin Endocrinol Metab，1995，80：178-182.

15. Atiya AW，Moldovan S，Adrian TE，et al.Intraislet somatostatin inhibits insulin（via a subtype somatostatin receptor）but not islet amyloid polypeptide secretion in the isolated perfused human pancreas.J Gastrointest Surg，1997，1：251-256.

16.王燕萍，刘礼斌.GLP-1对胰岛β细胞保护作用的研究进展.国际内分泌代谢杂志，2007，27（2）：98-100.

17. Larhammar D，Blomqvist AG，Soderberg C. Evolution of neuropeptide Y and tis related peptides. Comp Biochem Physiol，1993，106C：743-752.

18. Miguel J，Larhammar D. Neuropeptide Y family of peptides：Structrue，anatomical expression，function，and molecular evolution.Biochem Cell Biol，2000，78（3）：371-392.

19. Holst JJ.Glucagon-like peptide-1：from extract to agent. The Claude Bernard Lecture，2005. Diabetologia，2006，49：253-260.

20. Vilsboll T.The effects of glucagon-like peptide-l on the beta cell.Diab，Obes Metabol，2009，11（Supp13）：11-18.

21. Shao W，Yu Z，Fantus IG.Cyclic AMP signaling stimulates proteasome degradation of thioredoxin interacting protein （TxNIP）in pancreatic beta-cells. Cell Signal，2010，22 （08）：1240-1246.

22. Drucker DJ.Enhancing incretin action for the treatment of type2 diabetes.Diabetes Care，2003，26：2929-2940.

23. Wierup N，Svensson H，Mulder H，et al.The ghrelin cell：a novel developmentally regulated islet cell in the human pancreas.Regul Pept，2002，107：63-69.

24.李琳，吴永华，洪天配，等.Ghrelin抑制胰岛β细胞胰岛素释放的机制探讨.中国糖尿病杂志，2006，14（6）：452-454.

25. Wierup N，Yang S，McEvilly RJ，et al.Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1（832/13）cells.J Histochem Cytochem，2004，52（3）：301-310.

26. Dezaki K，Hosoda H，Kakei M，et al.Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells：implication in the glycemic control in rodents.Diabetes，2004，53：3142-3151.

27. Qader SS，Lundquist I，Ekelund M，et al.Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release.Regul Pept，2005，128：51-56.